Dr. Jordan Vaughn

Yeah, I mean, basically, I mean, they would have said, well, good point. Let's investigate them. But again, I mean, this was a time when basically everyone deferred to, unfortunately, basically an octogenarian that literally had not seen a patient probably in 50 years. And that's not necessarily on the ground clinically. They don't really have the evidence to understand the disease process.

Yeah, I mean, basically, I mean, they would have said, well, good point. Let's investigate them. But again, I mean, this was a time when basically everyone deferred to, unfortunately, basically an octogenarian that literally had not seen a patient probably in 50 years. And that's not necessarily on the ground clinically. They don't really have the evidence to understand the disease process.

And to understand the disease process is what allows you to even understand how a vaccine might work, by the way.

And to understand the disease process is what allows you to even understand how a vaccine might work, by the way.

Yeah, so basically I started out being somebody that understood that basically COVID was more of a vascular issue, mainly because it attaches the ACE2 receptor, causes vascular inflammation, damages the inside of vessels. And even when we think about why ventilators were so ineffective,

Yeah, so basically I started out being somebody that understood that basically COVID was more of a vascular issue, mainly because it attaches the ACE2 receptor, causes vascular inflammation, damages the inside of vessels. And even when we think about why ventilators were so ineffective,

The people that were kind of my mentors out of South Africa, Jocko Lobsher and Risha Pretorius, as well as Doug Kell out of the University of Liverpool, it was pretty obvious by the summer of 2020 that we were dealing with a vascular disease of the lungs, not a typical ARDS or an acute respiratory distress syndrome.

The people that were kind of my mentors out of South Africa, Jocko Lobsher and Risha Pretorius, as well as Doug Kell out of the University of Liverpool, it was pretty obvious by the summer of 2020 that we were dealing with a vascular disease of the lungs, not a typical ARDS or an acute respiratory distress syndrome.

And the worst thing we could have done was increase the intrathoracic pressure and close down more vessels because all we were going to do is actually make it harder for you to oxygenate. So what we started to do was utilize anticoagulants

And the worst thing we could have done was increase the intrathoracic pressure and close down more vessels because all we were going to do is actually make it harder for you to oxygenate. So what we started to do was utilize anticoagulants

and other things to calm down the inflammation, but also get rid of the vascular consequences and clotting consequences of the disease and actually had really incredible success. I mean, we're talking like I would pull people out of the hospital. I wasn't very popular and put them on home oxygen, put them on anticoagulants, visit them. And we probably did that on about 600 people. Okay.

and other things to calm down the inflammation, but also get rid of the vascular consequences and clotting consequences of the disease and actually had really incredible success. I mean, we're talking like I would pull people out of the hospital. I wasn't very popular and put them on home oxygen, put them on anticoagulants, visit them. And we probably did that on about 600 people. Okay.

So I started to get a reputation for actually getting people to actually survive. And then what started to happen is a lot of these younger people showed up that never even really knew they had COVID, except maybe some of my NCAA athletes might have tested positive during an event. And then all of a sudden they couldn't run anymore or they were stuck in bed.

So I started to get a reputation for actually getting people to actually survive. And then what started to happen is a lot of these younger people showed up that never even really knew they had COVID, except maybe some of my NCAA athletes might have tested positive during an event. And then all of a sudden they couldn't run anymore or they were stuck in bed.

And I mean, these are 19, 20 year olds that it was pretty obvious something's wrong. And they come to me and say, hey, we heard you can help. And I said, oh, I didn't know that I was telling people I could help. But that meant that I had to learn it. Good enough was that the understanding of the acute process allowed me to understand what long COVID and the vaccine injuries from spike protein are.

And I mean, these are 19, 20 year olds that it was pretty obvious something's wrong. And they come to me and say, hey, we heard you can help. And I said, oh, I didn't know that I was telling people I could help. But that meant that I had to learn it. Good enough was that the understanding of the acute process allowed me to understand what long COVID and the vaccine injuries from spike protein are.

And so that's really, again, my background, I'm an internist, but my undergrad's in engineering. So I'm kind of a problem solver. And a lot of it was just like, well, I got to learn this now. Let's try to figure out how to help people. And that's really what clinical medicine is all about. The problem is, is the current medical system in the NIH has beat that out of doctors.

And so that's really, again, my background, I'm an internist, but my undergrad's in engineering. So I'm kind of a problem solver. And a lot of it was just like, well, I got to learn this now. Let's try to figure out how to help people. And that's really what clinical medicine is all about. The problem is, is the current medical system in the NIH has beat that out of doctors.

And we've turned into like basically crass people that follow protocols and are going to be replaced by AI tomorrow. Yeah.

And we've turned into like basically crass people that follow protocols and are going to be replaced by AI tomorrow. Yeah.